S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
Log in

Hikma Pharmaceuticals News Headlines (OTCMKTS:HKMPF)

$23.00
0.00 (0.00 %)
(As of 01/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.00
Now: $23.00▼
$23.00
50-Day Range
$23.00
MA: $25.38▼
$26.00
52-Week Range
$20.08
Now: $23.00▼
$26.65
VolumeN/A
Average Volume1,059 shs
Market Capitalization$5.54 billion
P/E Ratio16.67
Dividend YieldN/A
Beta0.12

Headlines

Hikma Pharmaceuticals (OTCMKTS HKMPF) News Headlines

Source:
DateHeadline
Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF) to Post FY2019 Earnings of $1.46 Per Share, Jefferies Financial Group ForecastsHikma Pharmaceuticals Plc (OTCMKTS:HKMPF) to Post FY2019 Earnings of $1.46 Per Share, Jefferies Financial Group Forecasts
www.americanbankingnews.com - January 24 at 6:54 AM
FY2024 Earnings Forecast for Hikma Pharmaceuticals Plc Issued By Jefferies Financial Group (OTCMKTS:HKMPF)FY2024 Earnings Forecast for Hikma Pharmaceuticals Plc Issued By Jefferies Financial Group (OTCMKTS:HKMPF)
www.americanbankingnews.com - January 23 at 9:59 AM
Hikma Pharmaceuticals Signs Distribution Deal In Egypt With ChiesiHikma Pharmaceuticals Signs Distribution Deal In Egypt With Chiesi
www.lse.co.uk - January 13 at 6:38 AM
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technologyHikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
finance.yahoo.com - January 9 at 3:10 AM
Hikma Pharmaceuticals PLC's (LON:HIK) 1.4% Dividend Yield Looks Pretty InterestingHikma Pharmaceuticals PLC's (LON:HIK) 1.4% Dividend Yield Looks Pretty Interesting
finance.yahoo.com - January 2 at 11:44 AM
Amarins Patent Infringement Lawsuit, And Other News: The Good, Bad, And Ugly Of BiopharmaAmarin's Patent Infringement Lawsuit, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - January 2 at 3:45 AM
Estimating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)Estimating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
finance.yahoo.com - December 31 at 9:06 PM
Can Hikma Pharmaceuticals PLC's (LON:HIK) ROE Continue To Surpass The Industry Average?Can Hikma Pharmaceuticals PLC's (LON:HIK) ROE Continue To Surpass The Industry Average?
finance.yahoo.com - September 16 at 10:08 AM
HKMPF or ZTS: Which Is the Better Value Stock Right Now?HKMPF or ZTS: Which Is the Better Value Stock Right Now?
finance.yahoo.com - August 14 at 10:20 AM
Edited Transcript of HIK.L earnings conference call or presentation 9-Aug-19 8:30am GMTEdited Transcript of HIK.L earnings conference call or presentation 9-Aug-19 8:30am GMT
finance.yahoo.com - August 9 at 4:59 PM
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the HomePillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
finance.yahoo.com - May 29 at 10:35 AM
Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USPHikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP
finance.yahoo.com - May 13 at 10:50 AM
Hikma Sponsors MIT Grand Hack to Support Global Healthcare InnovationHikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation
finance.yahoo.com - May 13 at 10:50 AM
Ironwood Commences Phase I Study on IW-6463 for CNS DisordersIronwood Commences Phase I Study on IW-6463 for CNS Disorders
finance.yahoo.com - January 24 at 4:32 PM
Ocular (OCUL) Submits an sNDA for Eye Pain Drug DextenzaOcular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza
finance.yahoo.com - January 11 at 4:25 PM
Karyopharm Files MAA for Myeloma Candidate Selinexor in EUKaryopharm Files MAA for Myeloma Candidate Selinexor in EU
finance.yahoo.com - January 9 at 10:37 AM
Flexion Starts Phase III Enrollment on Zilretta for Hip OAFlexion Starts Phase III Enrollment on Zilretta for Hip OA
finance.yahoo.com - January 3 at 4:06 PM
Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib StudySpectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study
finance.yahoo.com - January 3 at 4:06 PM
Spectrum Pharma Files BLA for Neutropenia Candidate RolontisSpectrum Pharma Files BLA for Neutropenia Candidate Rolontis
finance.yahoo.com - December 28 at 10:29 AM
Hikma Pharmaceuticals Plc (HKMPF)Hikma Pharmaceuticals Plc (HKMPF)
www.zacks.com - December 25 at 3:54 PM
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: What are economic reports?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel